nach oben

Oral Cancer

Erschienen in:

29.10.2019 | Original Article

XRCC1 (rs25487) polymorphism is associated with severe oral mucositis and poor treatment response after radiotherapy for oropharyngeal carcinoma

verfasst von: Ankita Gupta, Don Mathew, Sushmita Ghoshal, Arnab Pal

Erschienen in: Oral Cancer | Ausgabe 3-4/2019

Einloggen, um Zugang zu erhalten

Abstract

Aim

To investigate the association of Single Nucleotide Polymorphisms of DNA repair genes and patient-specific clinical characteristics with the risk of developing severe acute radiotoxicities and treatment response in Oropharyngeal Carcinoma.

Methods

179 cases of Oropharyngeal Carcinoma treated with 2-D radical radiotherapy were evaluated for acute radiotoxicity end-points viz; oral mucositis, dermatitis, dysphagia, and xerostomia; and the resultant requirement of nasogastric feeding tube, significant (> 10%) weight loss during treatment and treatment break(s). Eleven Single Nucleotide Polymorphisms of DNA repair genes were analyzed using Polymerase Chain Reaction and Restriction Fragment Length Polymorphism and correlated with the severity of these radiotoxicities (Common Toxicity Criteria for Adverse Events v4.0 grading) and the treatment response. Clinical parameters like age, Karnofsky Performance Status, smoking and tobacco chewing, etc. were also analysed in relation to the above.

Results

Homozygous AA genotype of XRCC1 (rs25487) (p = 0.024*, OR 2.629, 95% CI 1.136–6.087), Karnofsky Performance Status < 80 (p = 0.050*, OR 2.723, CI 1.000–7.418) and history of tobacco chewing (p = 0.030*, OR 2.615, 95% CI 1.099–6.222) were independent predictive factors for increased risk of severe (≥ grade 3) mucositis. Also, the presence of Homozygous AA genotype of XRCC1(rs25487) was significantly associated with poor response to radiotherapy in these patients (p = 0.014, OR 2.235, 95% CI 1.074–5.744).

Conclusion

Our findings illustrate that patients with Homozygous AA genotype of XRCC1 (rs25487) and certain clinical characteristics are likely to develop severe acute mucositis after radiotherapy for Oropharyngeal Carcinoma and the presence of this polymorphism is also associated with poor response to treatment.

Nur mit Berechtigung zugänglich

Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45(4–5):309–316PubMedCrossRef

Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS (2016) The Indian scenario of head and neck oncology - challenging the dogmas. South Asian J Cancer 5(3):105–110PubMedPubMedCentralCrossRef

Pignon JP, le Maitre A, Maillard E, Bourhis J, Group M-NC (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92(1):4–14CrossRef

Ghoshal S, Goda JS, Mallick I, Kehwar TS, Sharma SC (2008) Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck–a phase III trial from a single institution in India. Clin Oncol (R Coll Radiol) 20(3):212–220CrossRef

Rishi A, Ghoshal S, Verma R, Oinam AS, Patil VM, Mohinder R et al (2013) Comparison of concomitant boost radiotherapy against concurrent chemoradiation in locally advanced oropharyngeal cancers: a phase III randomised trial. Radiother Oncol 107(3):317–324PubMedCrossRef

Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP (2018) Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma. PLoS ONE 13(7):e0200137PubMedPubMedCentralCrossRef

Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26(21):3582–3589PubMedPubMedCentralCrossRef

Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66(3):253–262PubMedCrossRef

Corry J, Peters LJ, Rischin D (2010) Optimising the therapeutic ratio in head and neck cancer. Lancet Oncol 11(3):287–291PubMedCrossRef

10.

Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ (2008) Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 26(22):3770–3776PubMedCrossRef

11.

Parliament MB, Murray D (2010) Single nucleotide polymorphisms of DNA repair genes as predictors of radioresponse. Semin Radiat Oncol 20(4):232–240PubMedCrossRef

12.

Popanda O, Marquardt JU, Chang-Claude J, Schmezer P (2009) Genetic variation in normal tissue toxicity induced by ionizing radiation. Mutat Res 667(1–2):58–69PubMedCrossRef

13.

Chistiakov DA, Voronova NV, Chistiakov PA (2008) Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncol 47(5):809–824PubMedCrossRef

14.

Jackson SP (2002) Sensing and repairing DNA double-strand breaks. Carcinogenesis 23(5):687–696PubMedCrossRef

15.

Christmann M, Tomicic MT, Roos WP, Kaina B (2003) Mechanisms of human DNA repair: an update. Toxicology 193(1–2):3–34PubMedCrossRef

16.

Alsbeih G, Al-Harbi N, Al-Hadyan K, El-Sebaie M, Al-Rajhi N (2010) Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes. Radiat Res 173(4):505–511PubMedCrossRef

17.

Li H, You Y, Lin C, Zheng M, Hong C, Chen J et al (2013) XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients. Radiat Oncol 8:31PubMedPubMedCentralCrossRef

18.

Kornguth DG, Garden AS, Zheng Y, Dahlstrom KR, Wei Q, Sturgis EM (2005) Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants. Int J Radiat Oncol Biol Phys 62(3):665–671PubMedCrossRef

19.

Werbrouck J, De Ruyck K, Duprez F, Veldeman L, Claes K, Van Eijkeren M et al (2009) Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys 73(4):1187–1195PubMedCrossRef

20.

Bourguignon MH, Gisone PA, Perez MR, Michelin S, Dubner D, Giorgio MD et al (2005) Genetic and epigenetic features in radiation sensitivity. Part II: implications for clinical practice and radiation protection. Eur J Nucl Med Mol Imaging 32(3):351–368PubMedCrossRef

21.

Andreassen CN, Alsner J, Overgaard M, Overgaard J (2003) Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 69(2):127–135PubMedCrossRef

22.

Andreassen CN, Alsner J (2009) Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother Oncol 92(3):299–309PubMedCrossRef

23.

Pratesi N, Mangoni M, Mancini I, Paiar F, Simi L, Livi L et al (2011) Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. Radiother Oncol 99(3):356–361PubMedCrossRef

24.

Bansal M, Mohanti BK, Shah N, Chaudhry R, Bahadur S, Shukla NK (2004) Radiation related morbidities and their impact on quality of life in head and neck cancer patients receiving radical radiotherapy. Qual Life Res 13(2):481–488PubMedCrossRef

25.

Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD et al (2009) Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 9(2):134–142PubMedPubMedCentralCrossRef

26.

Ota M, Fukushima H, Kulski JK, Inoko H (2007) Single nucleotide polymorphism detection by polymerase chain reaction-restriction fragment length polymorphism. Nat Protoc 2(11):2857–2864PubMedCrossRef

27.

Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176–181PubMedCrossRef

28.

Munshi A, Pandey MB, Durga T, Pandey KC, Bahadur S, Mohanti BK (2003) Weight loss during radiotherapy for head and neck malignancies: What factors impact it? Nutr Cancer 47(2):136–140PubMedCrossRef

29.

Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47(1):207–214PubMedCrossRef

30.

Paleri V, Urbano TG, Mehanna H, Repanos C, Lancaster J, Roques T et al (2016) Management of neck metastases in head and neck cancer: United Kingdom national multidisciplinary guidelines. J Laryngol Otol 130(S2):S161–S169PubMedPubMedCentralCrossRef

31.

Mendenhall WM, Million RR (1986) Elective neck irradiation for squamous cell carcinoma of the head and neck: analysis of time-dose factors and causes of failure. Int J Radiat Oncol Biol Phys 12(5):741–746PubMedCrossRef

32.

Maria OM, Eliopoulos N, Muanza T (2017) Radiation-Induced Oral Mucositis. Front Oncol 7:89PubMedPubMedCentralCrossRef

33.

Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35PubMedPubMedCentralCrossRef

34.

Murthy V, Calcuttawala A, Chadha K, d’Cruz A, Krishnamurthy A, Mallick I et al (2017) Human papillomavirus in head and neck cancer in India: current status and consensus recommendations. South Asian J Cancer 6(3):93–98PubMedPubMedCentralCrossRef

35.

Murthy V, Swain M, Teni T, Pawar S, Kalkar P, Patil A et al (2016) Human papillomavirus/p16 positive head and neck cancer in India: prevalence, clinical impact, and influence of tobacco use. Indian J Cancer 53(3):387–393PubMed

36.

Stur E, Agostini LP, Garcia FM, Peterle GT, Maia LL, Mendes SO et al (2015) Prognostic significance of head and neck squamous cell carcinoma repair gene polymorphism. Genet Mol Res 14(4):12446–12454PubMedCrossRef

37.

Tao Z, Gao J, Qian L, Huang Y, Zhou Y, Yang L et al (2017) Factors associated with acute oral mucosal reaction induced by radiotherapy in head and neck squamous cell carcinoma: a retrospective single-center experience. Medicine (Baltimore) 96(50):e8446CrossRef

38.

Saito N, Imai Y, Muto T, Sairenchi T (2012) Low body mass index as a risk factor of moderate to severe oral mucositis in oral cancer patients with radiotherapy. Support Care Cancer 20(12):3373–3377PubMedCrossRef

39.

Nourissat A, Bairati I, Samson E, Fortin A, Gelinas M, Nabid A et al (2010) Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer. Cancer 116(9):2275–2283PubMed

40.

Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA et al (2016) Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Radiother Oncol 121(3):431–439PubMedPubMedCentralCrossRef

Titel: XRCC1 (rs25487) polymorphism is associated with severe oral mucositis and poor treatment response after radiotherapy for oropharyngeal carcinoma
verfasst von: Ankita Gupta
Don Mathew
Sushmita Ghoshal
Arnab Pal
Publikationsdatum: 29.10.2019
Verlag: Springer International Publishing
Erschienen in: Oral Cancer / Ausgabe 3-4/2019
Elektronische ISSN: 2509-8837
DOI: https://doi.org/10.1007/s41548-019-00021-x

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen